Editorial
Dear reader,
Welcome to the EU Innovation Trends weekly newsletter!
To receive daily news on EU funding, innovation and digital issues, please register on our news portal EU Innovation Trends.
We are continuing our series of newsletters presenting different funding sectors or innovation topics. Contact us to discover how your organisation can be presented in the Focus of the Week. Actually, your organisation's activities can be the Focus of the Week including ads in our daily news.
In today’s Focus of the Week we will get an update on Innovations in health!
Enjoy reading this edition of our newsletter!
Roland Strauss and the EU Innovation Trends team |
|
| Focus of the week: Innovations in health |
|
|
Through Horizon 2020, its research programme, the EU is set to spend almost €7.5 bn on research to improve European healthcarebetween 2014 and 2020.
One of the main innovative health programmes run by the EU is the Innovative Medicines Initiative (IMI). They work towards improving health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. The IMI do this by facilitating collaboration between the key players involved in healthcare research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world's biggest public-private partnership (PPP) in the life sciences. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Through the IMI2 programme, we have a €3.3 billion budget for the period 2014-2020. |
|
News & Events Leading the fight against antimicrobial resistance EU-funded researchers have shown how nanoparticles can deliver drugs directly to the site of an infection. This preclinical research promises more effective treatments and the prospect of bypassing the threat of antimicrobial resistance.
Read more Complex diseases get the big data treatment The big data explosion, which allows scientists to analyse factors such as people’s lifestyles, genes and medical records to develop personalised treatments for conditions, has so far mostly benefited rare diseases with simple causes. But now, complex problems such as cardiovascular disease and dementia are getting the big data treatment.
Read more
E-health solutions to support cancer rehabilitation
Active rehabilitation has emerged as a powerful tool in cancer care. However, its full potential to help restore survivors' functional capacity, boost their quality of life and possibly even reduce the risk of recurrence has yet to be tapped. EU-funded researchers are looking into e-health solutions to take the technique another step further.
Read More |
Calls for Proposals
Demonstration pilots for implementation of personalised medicine in healthcare Personalised medicine (PM) has the potential to respond to, among others, the increasing burden of co-morbidities and thus enhance the sustainability of healthcare systems. With the increasing number of scientific approaches avai..... Original source
Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases Despite major advances in development of new drugs and vaccines against infectious diseases, many of the therapies and preventive measures do not result in the expected favourable health outcomes for various reasons. The pathogen might be resistant to the treatment.... Original source
Visionary and integrated solutions to improve well-being and health in cities It is estimated that by 2050 up to 70% of the world’s population will be living in urban areas. Urbanisation affects human health and well-being through factors such as exposure to pollutants, including noise, disasters, stressors and diseases, urban density, lack of physical activity, degrade... Original source |
|
Successful roll-out of EUR 400m natural capital initiative supporting conservation across Europe
Crucial new investment to strengthen green infrastructure, benefit biodiversity and adapt infrastructure to a changing climate has been unlocked by the Natural Capital Financial Facility, a EUR 400 million initiative intended to better protect Europe’s natural capital. |
|
EIB supports connectivity in Western Balkans
An EIB delegation led by Vice-President Dario Scannapieco, responsible for operations in the Western Balkans, welcomed Kosovo1 Finance Minister Bedri Hamza at the EIB’s headquarters in Luxembourg today. On the occasion, a EUR 80 million EIB loan to Kosovo was signed for the construction of a new 30 km single carriageway motorway on Route 6b between Peja and Kijeve. |
|
Surfing microwaves to success
When they noticed a bottleneck in bringing potentially life-saving medical microwave imaging (MWI) products to patients, researchers Raquel Conceicão and Martin O’Halloran did not think twice about teaming up. |
|
04 June 2018 - EIT Digital AI Monday - an event for AI explorers
Hydropower is currently the largest source of renewable power worldwide, and therefore an important contributor to low-carbon “clean development”. However, the development of hydropower has also been extensively criticised over many years because of its potential negative environmental and social impacts. |
|
13 June 2018 - EUROPEAN INNOVATION HUB DAY (EIH-Day)
The European Innovation Hub Day (EIH-Day), organised by CEA Tech in Grenoble, is a full day event dedicated to EIH and the use of associated European research and innovation programmes. |
|
14 June 2018 - Vienna Initiative Working Group
On June 14th, the third meeting of the ‘Vienna Initiative Working Group on IFI instruments supporting investment’ takes place from 10:00 to 17:00 at the EIB’s headquarters in Luxembourg. |
|
|
| | | | Inspiring impact innovations |
|
|
| | | Quarterly wins readers worldwise |
|
|
|
|
|
